PillTracker News
4 articles
PillTracker Ltd. Joins PMatX Innovation Lab, to Accelerate Development With Support From Merck, Flex and Israel Innovation Authority
Israeli medication adherence start-up PillTracker has joined the PMatX Innovation Lab to accelerate the development of its medication adherence solution. The lab, operated by M Ventures and supported by Merck, FLEX, and the Israel Innovation Authority, serves as an innovation lab for Israeli start-ups developing next-generation electronics innovations. PillTrackers technology, which uses cellular-enabled smart packaging and cloud-connectivity, initially targets medication adherence in clinical trials and will expand to support patient compliance for post-market specialty pharmaceuticals. The company will receive funding and strategic mentorship support from Merck, Flex, and the Israel Innovation Authority through the PMatX program. PillTracker aims to launch its next-generation clinical trial medication compliance platform in Q2 2020.
Partners
BIRD to invest $7 million in 8 new Israel-US projects
The Israel-US Binational Industrial Research and Development (BIRD) Foundation has approved $7 million in funding for eight new projects between American and Israeli companies. The projects cover various areas such as autonomous vehicles, biotechnology, digital health, homeland security, and nanotechnology. The funding from BIRD will be supplemented by private sector funding, bringing the total value of the projects to approximately $18.5 million. The BIRD Foundation has been instrumental in promoting collaboration between US and Israeli companies, with a total investment of about $340 million in joint projects. This funding will further support the growth and development of valuable collaborations between companies in both countries.
Investment
https://www.jpost.com/Israel-News/Israel-US-foundation-commits-7m-to-eight-hi-tech-R-and-D-partnerships-498221
The Israel-US Binational Industrial Research and Development Foundation (BIRD) will invest $7 million in eight new Israeli-American projects across various hi-tech disciplines. The projects will receive conditional grants of up to $1 million each, focusing on topics such as autonomous vehicles, biotechnology, digital health, homeland security, and nanotechnology. The companies involved will also have access to private sector funding, bringing the total value of the projects to $18.5 million. The funding was approved on June 14 at a BIRD board of governors meeting in Washington. BIRD, established in 1977, has invested over $340 million in joint projects, generating more than $10 billion in direct and indirect revenue.
Investment
BIRD - Israel-U.S. Binational Industrial R&D Foundation to Invest $7 Million in Eight New Projects
The BIRD Foundation, a collaboration between U.S. and Israeli companies, has approved $7 million in funding for eight new projects. These projects will also access private sector funding, bringing the total value to approximately $18.5 million. The BIRD Foundation promotes joint product development and provides grants of up to $1 million for approved projects. The projects approved cover a range of technological fields, including 3D culture platforms, colon cancer screening systems, and personalized nutrition recommendations. The BIRD Foundation has approved over 940 projects in its 40-year history, with a total investment of about $340 million. The deadline for the next project cycle is September 7, 2017.
PartnersInvestment